Syngene downgrades its revenue guidance by 5% on Librela inventory impact (Soban News)

Syngene trims FY26 revenue guidance by up to 5% as inventory correction for veterinary drug Librela hits profits, even as core research and CDMO business grows​Syngene trims FY26 revenue guidance by up to 5% as inventory correction for veterinary drug Librela hits profits, even as core research and CDMO business grows ​Latest News [ SOBAN NEWS: International and National ]